Copyright
©The Author(s) 2016.
World J Stem Cells. Nov 26, 2016; 8(11): 384-395
Published online Nov 26, 2016. doi: 10.4252/wjsc.v8.i11.384
Published online Nov 26, 2016. doi: 10.4252/wjsc.v8.i11.384
Table 2 Genes mutated along with the CTNNB1 alteration
Gene symbol | Gene title | Cytoband | Mutation percentage | Log ratio | P-value | Ratio of GC cells to MSCs | |
In altered group | In unaltered group | ||||||
EPHA8 | EPH receptor A8 | 1p36.12 | 29.17% | 2.28% | 3.68 | 1.45E-05 | Signal intensity is low |
SS18 | Synovial sarcoma translocation Chromosome 18 | 18q11.2 | 16.67% | 0.00% | > 10 | 3.84E-05 | 0.6 |
1.4 | |||||||
ICE1 | Interactor of little elongator complex ELL subunit 1 | 5p15.32 | 33.33% | 4.56% | 2.87 | 4.74E-05 | 1.5 |
PTCH1 | Patched 1 | 9q22.3 | 29.17% | 3.42% | 3.09 | 8.16E-05 | 16.6 |
MSH3 | MutS homolog 3 | 5q14.1 | 20.83% | 1.14% | 4.19 | 1.28E-04 | Signal intensity is low |
CARD11 | Caspase recruitment domain family, member 11 | 7p22 | 29.17% | 4.18% | 2.8 | 2.03E-04 | Signal intensity is low |
- Citation: Tanabe S, Kawabata T, Aoyagi K, Yokozaki H, Sasaki H. Gene expression and pathway analysis of CTNNB1 in cancer and stem cells. World J Stem Cells 2016; 8(11): 384-395
- URL: https://www.wjgnet.com/1948-0210/full/v8/i11/384.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v8.i11.384